Phibro Animal Health Co. to Issue Quarterly Dividend of $0.12 (NASDAQ:PAHC)

Phibro Animal Health Co. (NASDAQ:PAHC - Get Free Report) announced a quarterly dividend on Tuesday, February 4th,RTT News reports. Shareholders of record on Wednesday, March 5th will be given a dividend of 0.12 per share on Wednesday, March 26th. This represents a $0.48 dividend on an annualized basis and a yield of 2.03%. The ex-dividend date of this dividend is Wednesday, March 5th.

Phibro Animal Health has a payout ratio of 25.7% indicating that its dividend is sufficiently covered by earnings. Equities analysts expect Phibro Animal Health to earn $1.95 per share next year, which means the company should continue to be able to cover its $0.48 annual dividend with an expected future payout ratio of 24.6%.

Phibro Animal Health Stock Down 3.6 %

PAHC stock traded down $0.89 during mid-day trading on Friday, hitting $23.69. The stock had a trading volume of 330,418 shares, compared to its average volume of 137,832. The stock has a market capitalization of $959.45 million, a price-to-earnings ratio of 49.35, a PEG ratio of 0.53 and a beta of 0.52. The company has a current ratio of 3.20, a quick ratio of 1.69 and a debt-to-equity ratio of 2.99. Phibro Animal Health has a 1-year low of $10.03 and a 1-year high of $25.98. The company has a fifty day moving average of $21.90 and a 200 day moving average of $21.66.

Phibro Animal Health (NASDAQ:PAHC - Get Free Report) last issued its quarterly earnings data on Wednesday, February 5th. The company reported $0.54 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.40 by $0.14. Phibro Animal Health had a net margin of 1.75% and a return on equity of 25.35%. On average, equities analysts expect that Phibro Animal Health will post 1.94 EPS for the current fiscal year.

Analysts Set New Price Targets

A number of brokerages recently issued reports on PAHC. StockNews.com lowered shares of Phibro Animal Health from a "strong-buy" rating to a "buy" rating in a research report on Thursday. Morgan Stanley upped their target price on Phibro Animal Health from $20.00 to $25.00 and gave the company an "equal weight" rating in a research note on Tuesday, December 17th. Finally, Barclays lifted their target price on shares of Phibro Animal Health from $13.00 to $20.00 and gave the company an "underweight" rating in a research report on Tuesday, November 12th. Two research analysts have rated the stock with a sell rating, two have issued a hold rating and one has given a buy rating to the company's stock. According to data from MarketBeat, Phibro Animal Health presently has an average rating of "Hold" and a consensus price target of $20.50.

Phibro Animal Health Company Profile

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.